QGEN — QIAGEN NV

Ownership history in DNCA FINANCE  ·  3 quarters on record

This page tracks every 13F SEC filing in which DNCA FINANCE reported a position in QIAGEN NV (QGEN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.9% (2025 Q2)
Avg. % of fund
1.81%
First filed
2025 Q2
Last filed
2025 Q4
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 691,821 +133,340 +23.9% 1.83% $31.6M $44.97
2025 Q3 ADDED 558,481 +39,063 +7.5% 1.69% $24.7M $44.68
2025 Q2 INITIATED 519,418 — — 1.90% $24.9M $47.81
% of Fund (quarterly)    QGEN price (monthly, adj. close)

Other funds also holding QGEN

As of 2025 Q4 — sorted by position size

NUANCE INVESTMENTS, LLC 3Y 7Y 3.98% Nitorum Capital, L.P. 3Y 7Y 2.43% PRENTISS SMITH & CO INC 3Y 7Y 2.31% Parkman Healthcare Partners LLC 3Y 2.12% Perbak Capital Partners LLP 1.32% Ilex Capital Partners (UK) LLP 1.31% EARNEST PARTNERS LLC 3Y 7Y 0.81% Moors & Cabot, Inc. 3Y 7Y 0.64% Arbejdsmarkedets Tillaegspension 0.58% Oak Harvest Investment Services 3Y 0.48%
← Back to DNCA FINANCE Holdings